SRPTNasdaq United States
Market cap
$1.772 B
$16.78 +0.00%
Close of 7 Aug 2026
Revenue
$2.20B
#1095 by revenue
Earnings
-$713.4M
Loss-making
Shares outstanding
105,627,021
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Sarepta Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.